Prof. Matthew Groves from the Groningen Research Institute of Pharmacy (GRIP) is partner in a consortium that has been awarded a H2020 Marie Curie ETN grant. The grant of EUR 3.2 million is for the MepAnti project, which aims to tackle the antimicrobial resistance problem by targeting enzymes of the methylerythritol phosphate pathway.
Antimicrobial resistance is a serious global health problem and, at present, there is no inter-institutional and interdisciplinary consortium explicitly focused on the discovery and development of novel anti-infective agents. The MepAnti consortium consists of nine academic partners and seven non-academic partners. The Helmholtz Institute for Pharmaceutical Research Saarland is coordinator. The consortium aims to go beyond the state-of-the-art in the anti-infective field by tackling the attractive and underexplored enzymes from the 2C-methyl-D-erythritol 4-phosphate (MEP) pathway.
Prof. Groves receives EUR 265,000 for his part in the project. He will provide structural biology and biophysical expertise, with a focus on the first and rate-limiting step catalyzed by DXS.
Prof. Slotboom co-applicant in awarded ZonMw project application
On Thursday 10 June, a partial solar eclipse will be visible in the Netherlands. The eclipse will start at 11.21 a.m., with a peak at 12.27 p.m. At 1.36 p.m., the eclipse will be over. Eclipse glasses will be handed out at five locations.
De vier Nederlandse solar teams (Delft, Eindhoven, Groningen, Twente) slaan de handen ineen tegen klimaatverandering De studententeams bouwen hun eigen zonneauto’s en ontwikkelen innovaties voor een duurzamere toekomst, maar zien tegelijkertijd dat...
The UG website uses functional and anonymous analytics cookies. Please answer the question of whether or not you want to accept other cookies (such as tracking cookies).
If no choice is made, only basic cookies will be stored. More information